IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy

被引:40
作者
Simkin, GO
Tao, JS
Levy, JG
Hunt, DWC
机构
[1] QLT PhotoTherapeut Inc, Dept Preclin Pharmacol, Vancouver, BC V5Z 4H5, Canada
[2] Univ British Columbia, Fac Sci, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada
[3] St Pauls Hosp Univ Brit Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
关键词
D O I
10.4049/jimmunol.164.5.2457
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have explored the effect of photodynamic therapy (PDT) with verteporfin on the induction and expression of contact hypersensitivity (CHS) to 2,4-dinitrofluorobenzene (DNFB) in normal mice and IL-10-deficient mice. Our results indicate that DNFB sensitized mice given PDT with verteporfin and whale body red light irradiation exhibited a significant reduction in CHS compared with control animals. Administration of rIL-12 reversed the effect(s) of PDT as did treatment of mice with anti-IL-10-neutralizing Ab. Knockout mice deficient in IL-10 were found to be resistant to the inhibitory effects of PDT. In vitro proliferative responses using spleen cells from DNFB-sensitized and PDT-treated mice showed a significantly lower response to DNBS as compared with cells from DNFB-sensitized mice or DNFB and PDT-treated IL-10-deficient mice. Finally, naive mice exposed to PDT exhibited an increase in skin IL-10 levels, which peaked between 72 and 120 h post-PDT. Together these data support the role of IL-10 as a key modulator in the inhibition of the CHS response by whole body PDT.
引用
收藏
页码:2457 / 2462
页数:6
相关论文
共 61 条
[1]   Functional diversity of helper T lymphocytes [J].
Abbas, AK ;
Murphy, KM ;
Sher, A .
NATURE, 1996, 383 (6603) :787-793
[2]  
ARANEO BA, 1989, J IMMUNOL, V143, P1737
[3]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[4]   INTERLEUKIN-10 BUT NOT INTERLEUKIN-4 IS A NATURAL SUPPRESSANT OF CUTANEOUS INFLAMMATORY RESPONSES [J].
BERG, DJ ;
LEACH, MW ;
KUHN, R ;
RAJEWSKY, K ;
MULLER, W ;
DAVIDSON, NJ ;
RENNICK, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) :99-108
[5]   Contact hypersensitivity in MHC class II-deficient mice depends on CD8 T lymphocytes primed by immunostimulating Langerhans cells [J].
Bouloc, A ;
Cavani, A ;
Katz, SI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (01) :44-49
[6]   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED CD8(+) T-CELLS AND CLASS II-RESTRICTED CD4(+) T-CELLS, RESPECTIVELY, MEDIATE AND REGULATE CONTACT SENSITIVITY TO DINITROFLUOROBENZENE [J].
BOUR, H ;
PEYRON, E ;
GAUCHERAND, M ;
GARRIGUE, JL ;
DESVIGNES, C ;
KAISERLIAN, D ;
REVILLARD, JP ;
NICOLAS, JF .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3006-3010
[7]   Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation [J].
Cella, M ;
Scheidegger, D ;
PalmerLehmann, K ;
Lane, P ;
Lanzavecchia, A ;
Alber, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :747-752
[8]   INTERLEUKIN-10 (IL-10) INHIBITS HUMAN LYMPHOCYTE INTERFERON GAMMA-PRODUCTION BY SUPPRESSING NATURAL-KILLER-CELL STIMULATORY FACTOR/IL-12 SYNTHESIS IN ACCESSORY CELLS [J].
DANDREA, A ;
ASTEAMEZAGA, M ;
VALIANTE, NM ;
MA, XJ ;
KUBIN, M ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :1041-1048
[9]  
Dilulio NA, 1996, EUR J IMMUNOL, V26, P2606
[10]   ACTIVATED DYES AS ANTITUMOR AGENTS [J].
DOUGHERTY, TJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (04) :1333-1336